Abstracts tagged "abatacept and magnetic resonance imaging (MRI)"

Abstract Number: 1521 • 2014 ACR/ARHP Annual Meeting
Sustained Improvements in Magnetic Resonance Imaging Outcomes with Abatacept Following the Withdrawal of All Treatment in Patients with Early Rheumatoid Arthritis
C Peterfy¹, Gerd Burmester², Vivian P. Bykerk³, B G Combe⁴, J C DiCarlo¹, Daniel E. Furst⁵, T W J Huizinga⁶, C S Karyekar⁷, D Wong⁷, Philip G. Conaghan⁸ and P Emery⁹, ¹Spire Sciences, Inc., Boca Raton, FL, ²Charité – University Medicine Berlin, Berlin, Germany, ³Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, ⁴Hôpital Lapeyronie, Montpellier, France, ⁵University of California at Los Angeles, Los Angeles, CA, ⁶Leiden University Medical Center, Leiden, Netherlands, ⁷Bristol-Myers Squibb, Princeton, NJ, ⁸NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁹University of Leeds, Leeds, United Kingdom
Background/Purpose: Biologic treatment can lead to improved clinical outcomes in early RA. In the Assessing Very Early Rheumatoid arthritis Treatment (AVERT) study, abatacept (ABA) +…